Scott Nickerson

Scott Nickerson possesses extensive experience in the pharmaceutical and biotechnology sectors, currently serving as the Senior Vice President of Individualized Neoantigen Therapy Manufacturing at Moderna. Previously held positions include Senior Vice President of US Manufacturing and Senior Vice President of Global Quality at Moderna, as well as Vice President of QA & QC at Alexion Pharmaceuticals. Scott's career also includes leadership roles at ImClone Systems as Associate Vice President and Senior Director of QA Compliance, and at Eli Lilly and Company, where Scott served as Interim Director of Quality Assurance for Bioproduct Research and Development, in addition to managerial responsibilities in quality assurance. Educational qualifications include a Master of Science in Analytical Chemistry from the University of Arizona and a Bachelor of Science in Chemistry from Hampden-Sydney College.